FDA.reportPublic FDA data

NDC 73377-068 - Atovaquone

This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.

Product NDC
73377-068
Package NDCs from labels
73377-068-01, 73377-068-02
Manufacturer
AX Pharmaceutical Corp
Effective date
2020-09-10
Current FDA listing
Not matched in FDA.report NDC product tables

DailyMed Labels#

Label, Manufacturer, Effective date table
LabelManufacturerEffective dateType
Atovaquone - AX Pharmaceutical CorpAX Pharmaceutical Corp2020-09-10BULK INGREDIENT

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDCProductDescriptionFormQuantityStrengthSPL version
73377-068-01Atovaquone500 g in 1 JARPOWDER5001
73377-068-02Atovaquone100 g in 1 JARPOWDER1001

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDCDashboard titleSPL versionValidationDashboard ZIP
73377-068ATOVAQUONE POWDER [AX PHARMACEUTICAL CORP]12 package rows20200911_43bc7032-b18a-45a0-94d6-d2b077c84daa.zip

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 2 of 2 · 29 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
ATOVAQUONEATOVAQUONE ORAL SUSPENSIONMajor Pharmaceuticals73e2297e-7cda-4abf-9fb7-8c67cb5638a32025-08-13Warnings, Adverse reactionsExact identifier
unii: Y883P1Z2LT
AtovaquoneATOVAQUONEATLANTIC BIOLOGICALS CORP.f99a8a0c-2b42-4da0-8f5a-e963fc619e8b2025-05-12Warnings, Adverse reactionsExact identifier
unii: Y883P1Z2LT
AtovaquoneATOVAQUONEAbon Pharmaceuticals, LLC2d3715ed-6ddc-4c10-9d2c-9c80cb1dfd082025-05-12Warnings, Adverse reactionsExact identifier
unii: Y883P1Z2LT
AtovaquoneATOVAQUONELohxaba3cad0d-cce9-424f-ba5c-557dba8bef122025-03-20Warnings, Adverse reactionsExact identifier
unii: Y883P1Z2LT
Atovaquone and Proguanil HydrochlorideATOVAQUONE AND PROGUANIL HYDROCHLORIDEProficient Rx LPe74b00fc-8743-4e9d-8a83-aab8e531b3ba2024-07-01Warnings, Adverse reactionsExact identifier
unii: Y883P1Z2LT
AtovaquoneATOVAQUONEChartwell RX, LLCde0e29b5-a4c7-405c-a5b9-438729d9ba3a2024-05-24Warnings, Adverse reactionsExact identifier
unii: Y883P1Z2LT
AtovaquoneATOVAQUONENorthStar RxLLCfc7bdd97-f780-4eed-80e0-72e70267b21a2024-04-12Warnings, Adverse reactionsExact identifier
unii: Y883P1Z2LT
Atovaquone and Proguanil HClATOVAQUONE AND PROGUANIL HYDROCHLORIDEA-S Medication Solutions593baf3d-bd9e-4a44-8f90-125aa4a7a99e2023-10-23Warnings, Adverse reactionsExact identifier
unii: Y883P1Z2LT
ATOVAQUONEATOVAQUONELupin Pharmaceuticals, Inc.03ddcc33-729c-4d46-ae6b-2ee47978ba162021-06-01Warnings, Adverse reactionsExact identifier
unii: Y883P1Z2LT

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.